AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

August 2, 2026·Source: CNBC·2 views

U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.

This story was originally reported by CNBC. For the complete coverage and latest updates, visit the original source.

Read the full story at CNBC.

Originally reported by CNBC. Read the original article

The earthquake struck off Flores island in the country's east early on Saturday morning.

Greenhouses and rented plots are lifelines for Gaza's farmers, helping them grow crops despite the extensive destruction

Water in the central terminal area means passengers cannot use roads to the airport

An emblem of the obstacles faced by women artists of her generation, she was 67 when her first museum retrospective opened to rave reviews in 2007.

Related Articles